Posts Tagged ‘Tocol Pharmaceuticals’

Tocol Pharmaceuticals is using cutting-edge technology to develop products inspired by nature to improve human health. The company recently received a $1 million investment from La Universidad Tecnica Particular de Loja (UTPL)  in Ecuador to introduce its radioprotection products into the South American market. Tocol was co-founded by Dr. Cesar Compadre and Dr. Philip Breen as part of […]

With assistance from the Arkansas Small Business and Technology Development Center, Tocol Pharmaceuticals and Fauxsee Innovations have won state funding to support ongoing product research and development. The Arkansas Economic Development Commission’s Division of Science and Technology recently announced awards to the two companies. ASBTDC has helped six technology-based companies secure $281,861 through state channels […]

Tocol Pharmaceuticals, a spinout company of the University of Arkansas for Medical Sciences, has developed a plant-based compound that shows great promise as a safe and effective method for protecting humans against exposure to radiation. The company recently received board approval for a $50,000 Seed Capital Investment Program award through the Arkansas Economic Development Commission’s Division of Science and Technology to […]